Vaccine technologies against avian influenza

Current approaches and new directions

Kathleen A. Ross, Lucas M. Huntimer, Julia E. Vela Ramirez, Justin R. Adams, Susan L. Carpenter, Marian L. Kohut, Tatiana K Bronich, Richard Webby, Kevin L. Legge, Surya K. Mallapragada, Michael J. Wannemuehler, Balaji Narasimhan

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on the unique and severe histopathological lesions induced by the virus. The severe pathological presentation of these infections has also prompted interest in identifying preventive and therapeutic approaches against HPAI. The potential severity of a HPAI pandemic and the efforts to identify effective intervention strategies have led to many novel discoveries in vaccine and antiviral development that are critically examined in this review.

Original languageEnglish (US)
Pages (from-to)2261-2294
Number of pages34
JournalJournal of Biomedical Nanotechnology
Volume10
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

Influenza in Birds
Vaccines
Viruses
Pandemics
Technology
Antiviral Agents
China
Infection
Research
Direction compound
Therapeutics

Keywords

  • Antiviral
  • H5N1
  • Highly pathogenic avian influenza
  • Pandemic
  • Vaccine

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Ross, K. A., Huntimer, L. M., Vela Ramirez, J. E., Adams, J. R., Carpenter, S. L., Kohut, M. L., ... Narasimhan, B. (2014). Vaccine technologies against avian influenza: Current approaches and new directions. Journal of Biomedical Nanotechnology, 10(9), 2261-2294. https://doi.org/10.1166/jbn.2014.1983

Vaccine technologies against avian influenza : Current approaches and new directions. / Ross, Kathleen A.; Huntimer, Lucas M.; Vela Ramirez, Julia E.; Adams, Justin R.; Carpenter, Susan L.; Kohut, Marian L.; Bronich, Tatiana K; Webby, Richard; Legge, Kevin L.; Mallapragada, Surya K.; Wannemuehler, Michael J.; Narasimhan, Balaji.

In: Journal of Biomedical Nanotechnology, Vol. 10, No. 9, 01.01.2014, p. 2261-2294.

Research output: Contribution to journalReview article

Ross, KA, Huntimer, LM, Vela Ramirez, JE, Adams, JR, Carpenter, SL, Kohut, ML, Bronich, TK, Webby, R, Legge, KL, Mallapragada, SK, Wannemuehler, MJ & Narasimhan, B 2014, 'Vaccine technologies against avian influenza: Current approaches and new directions', Journal of Biomedical Nanotechnology, vol. 10, no. 9, pp. 2261-2294. https://doi.org/10.1166/jbn.2014.1983
Ross KA, Huntimer LM, Vela Ramirez JE, Adams JR, Carpenter SL, Kohut ML et al. Vaccine technologies against avian influenza: Current approaches and new directions. Journal of Biomedical Nanotechnology. 2014 Jan 1;10(9):2261-2294. https://doi.org/10.1166/jbn.2014.1983
Ross, Kathleen A. ; Huntimer, Lucas M. ; Vela Ramirez, Julia E. ; Adams, Justin R. ; Carpenter, Susan L. ; Kohut, Marian L. ; Bronich, Tatiana K ; Webby, Richard ; Legge, Kevin L. ; Mallapragada, Surya K. ; Wannemuehler, Michael J. ; Narasimhan, Balaji. / Vaccine technologies against avian influenza : Current approaches and new directions. In: Journal of Biomedical Nanotechnology. 2014 ; Vol. 10, No. 9. pp. 2261-2294.
@article{5ee6fab6e006492784096b8cb62f853e,
title = "Vaccine technologies against avian influenza: Current approaches and new directions",
abstract = "The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on the unique and severe histopathological lesions induced by the virus. The severe pathological presentation of these infections has also prompted interest in identifying preventive and therapeutic approaches against HPAI. The potential severity of a HPAI pandemic and the efforts to identify effective intervention strategies have led to many novel discoveries in vaccine and antiviral development that are critically examined in this review.",
keywords = "Antiviral, H5N1, Highly pathogenic avian influenza, Pandemic, Vaccine",
author = "Ross, {Kathleen A.} and Huntimer, {Lucas M.} and {Vela Ramirez}, {Julia E.} and Adams, {Justin R.} and Carpenter, {Susan L.} and Kohut, {Marian L.} and Bronich, {Tatiana K} and Richard Webby and Legge, {Kevin L.} and Mallapragada, {Surya K.} and Wannemuehler, {Michael J.} and Balaji Narasimhan",
year = "2014",
month = "1",
day = "1",
doi = "10.1166/jbn.2014.1983",
language = "English (US)",
volume = "10",
pages = "2261--2294",
journal = "Journal of Biomedical Nanotechnology",
issn = "1550-7033",
publisher = "American Scientific Publishers",
number = "9",

}

TY - JOUR

T1 - Vaccine technologies against avian influenza

T2 - Current approaches and new directions

AU - Ross, Kathleen A.

AU - Huntimer, Lucas M.

AU - Vela Ramirez, Julia E.

AU - Adams, Justin R.

AU - Carpenter, Susan L.

AU - Kohut, Marian L.

AU - Bronich, Tatiana K

AU - Webby, Richard

AU - Legge, Kevin L.

AU - Mallapragada, Surya K.

AU - Wannemuehler, Michael J.

AU - Narasimhan, Balaji

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on the unique and severe histopathological lesions induced by the virus. The severe pathological presentation of these infections has also prompted interest in identifying preventive and therapeutic approaches against HPAI. The potential severity of a HPAI pandemic and the efforts to identify effective intervention strategies have led to many novel discoveries in vaccine and antiviral development that are critically examined in this review.

AB - The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on the unique and severe histopathological lesions induced by the virus. The severe pathological presentation of these infections has also prompted interest in identifying preventive and therapeutic approaches against HPAI. The potential severity of a HPAI pandemic and the efforts to identify effective intervention strategies have led to many novel discoveries in vaccine and antiviral development that are critically examined in this review.

KW - Antiviral

KW - H5N1

KW - Highly pathogenic avian influenza

KW - Pandemic

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84904869711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904869711&partnerID=8YFLogxK

U2 - 10.1166/jbn.2014.1983

DO - 10.1166/jbn.2014.1983

M3 - Review article

VL - 10

SP - 2261

EP - 2294

JO - Journal of Biomedical Nanotechnology

JF - Journal of Biomedical Nanotechnology

SN - 1550-7033

IS - 9

ER -